Abstract
Behçet’s Syndrome (BS) is a multi-system, vascular-inflammatory disease of unknown origin, involving the nervous system in a subgroup of patients. The growing clinical and imaging evidence suggests that primary neurological involvement in BS may be subclassified into two major forms: the first one, which is seen in the majority of patients, may be characterized as a vascular-inflammatory central nervous system (CNS) disease, with focal or multifocal parenchymal involvement mostly presenting with a subacute brainstem syndrome and hemiparesis; the other, which has few symptoms and a better neurological prognosis, may be caused by isolated cerebral venous sinus thrombosis and intracranial hypertension. These two types rarely occur in the same individual, and their pathogenesis is likely to be different. Isolated behavioral syndromes and peripheral nervous system involvement are rare, whereas a nonstructural vascular type headache is relatively common and independent from neurological involvement. Neurologic complications secondary to systemic involvement of BS such as cerebral emboli from cardiac complications of BS and increased intracranial pressure due to superior vena cava syndrome, as well as neurologic complications related to BS treatments such as CNS neurotoxicity with cyclosporine and peripheral neuropathy with the use of thalidomide or colchisin are considered as secondary neurological complications of this syndrome. As the neurological involvement in this syndrome is so heterogeneous, it is difficult to predict its course and prognosis, and response to treatment. Currently, treatment options are limited to attack and symptomatic therapies with no evidence for the efficacy of any long term preventive treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Akbulut L, Gur G, Bodur H, Alli N, Borman P (2007) Peripheral neuropathy in Behçet disease: an electroneurophysiological study. Clin Rheumatol 26:1240–1244
Akman-Demir G, Bahar S, Baykan-Kurt B, Gürvit IH, Serdaroğlu P (1996) Intracranial hypertension in Behçet’s Disease. Eur J Neurol 3:66–70
Akman-Demir G, Serdaroğlu P, Tasçi B and the Neuro-Behçet Study Group (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. Brain 122:2171–2181
Aktaş EG, Kaplan M, Ozveren MF (2008) Basilar artery aneurysm associated with Behçet’s Disease: a case report. Turk Neurosurg 18:35–38
Al-Araji A, Sharquie K, Al-Rawi Z (2003) Prevalence and patterns of neurological involvement in Behçet’s disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry 74:608–613
Atabay C, Erdem E, Kansu T, Eldem B (1992) Eales — disease with internuclear ophthalmoplegia. Ann Ophthalmol 24:267–270
Atasoy HT, Tunc TO, Unal AE, Emre U, et al. (2007) Peripheral nervous system involvement in patients with Behçet disease. The Neurologist 13:225–230
Aykutlu E, Baykan B, Serdaroğlu P, et al. (2002) Epileptic seizures in Behçet disease. Epilepsia 43:832–835
Aykutlu E, Baykan B, Akman-Demir G, Topcular B, Ertas M (2006) Headache in Behçet’s disease. Cephalalgia 26:180–186
Bahar S, Çoban O, Gürvit H, Akman-Demir F, Gökyiğit A (1993) Spontaneus dissection of the extracranial vertebral artery with spinal subarachnoid hemorrhage in a patient with Behçet’s disease. Neuroradiology 35:352–354
Behçet H (1937) Uber residivierende, aphtöse, durch ein virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Derm Woschenscr 105:1152–1157
Bogdanova D, Milanov I, Georgiev D (1998) Parkinsonian syndrome as a neurological manifestation of Behçet’s disease. Can J Neurol Sci 25:82–85
Bussone G, La Mantia L, Boiardi A, Giovannini P (1982) Chorea in Behçet’s Syndrome. J Neurol 227:89–92
Cetinel B, Obek C, Solok V, Yaycioglu O, Yazici H (1998) Urologic screening for men with Behçet’s syndrome. Urology 52:863–865
Fujikawa K, Aratake K, Kawakami A, Aramaki T, et al. (2007) Successful treatment of refractory neuro-Behçet’s disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile. Ann Rheum Dis 66:136–137
Gardner RC, Schmahmann JD (2008) Ataxia and cerebellar atrophy — a novel manifestation of neuro-Behçet disease? Mov Disord 23(2):308–309
Goodwin J (2008) The Vogt-Koyanagi-Harada syndrome. In: Gilman S (ed) MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com. Accessed 1 August 2008
Green AL, Mitchell PJ (2000) Spinal cord Neurobehçet’s disease detected on magnetic resonance imaging. Australasian Radiology 44:201–203
Hadfield MG, Aydın F, Lippman HR, Sanders KM (1997) Neuro-Behçet’s disease. Clin Neuropathol 16:55–60
Haghighi AB, Rahman P, Ali-Reza N (2007) The pathological presentations of neuro-Behçet disease: A case report and review of the literature. The Neurologist 13:209–214
Haghighi AB, Aflaki E, Ketabchi L (2008) The prevalence and characteristics of different types of headache in patients with Behçet’s disease, a case-control study. Headache 48:424–429
Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gül A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H (2008) EULAR recommendations for the management of Behçet’s disease: report of a task force of the European Standing Committee for International Clinical Sstudies Including Therapeutics (ESCISIT). Ann Rheum Dis 67(12):1656–1662
Hatzitolios A, Savopoulos C, Ntaios G, Tsirogianni E, Baltatzi M, Apostolopoulou M, Dimitrakoudi E (2008) Recurrent peripheral facial paresis may constitute the sole clinical manifestation in neuro-Behçet disease. Neurologist 14:77
Hirohata S, Suda H, Hashimoto T (1998) Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behçet’s disease. J Neurol Sci 14(159):181–185
Hirose M, Ikeuchi T, Hayashi S, et al. (2006) A possible variant of neuro-Behçet disease presenting with chronic progressive ataxia without mucocutaneo-ocular symptoms. Rheumatol Int 27:61–66
Hisanaga K, Iwasaki Y, Itoyama Y (2005). Neuro-Sweet disease: clinical manifestations and criteria for diagnosis. Neurology 64:1756–1761
Hisanaga K (2007) Neuro-neutrophilic disease: neuro-Behçet disease and neuro-Sweet disease. Intern Med 46:153–154
Hiwatashi A, Garber T, Moritani T, et al. (2003) Diffusion-weighted MR imaging of neuro-Behçet’s disease: a case report. Neuroradiology 45:468–471
Houman MH, Hamzaoui-B’Chir S, Ben Ghorbel I, et al. (2002) Neurologic manifestations of Behçet’s disease: analysis of a series of 27 patients. Rev Med Interne 23:592–606
Huang WS, Chiu PY, Kao A, et al. (2002) Decreased cerebral blood flow in neuro-Behçet’s syndrome patients with neuropsychiatric manifestations and normal magnetic resonance imaging — a preliminary report. J Neuroimaging 12:355–359
International Study Group for Behçet’s disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
International Study Group for Behçet’s disease (1992) Evaluation of diagnostic (classification) criteria in Behçet’s disease- towards internationally agreed criteria. Br J Rheumatol 31:299–308
Kang DW, Chu K, Cho JY, et al. (2001) Diffusion-weighted magnetic resonance imaging in neuro-Behçet’s disease. J Neurol Neurosurg Psychiatry 70:412–413
Kansu E (1996) Endothelial cell dysfunction in Behçet’s disease. In: Ansell BM, Bacon PA, Lie JT, Yazıcı H (eds) Vasculitides. London, Chapman&Hall, pp 207–221
Kansu T, Kirkali P, Kansu E, Zileli T (1989) Optic neuropathy in Behçet’s disease. J Clin Neuro Opthalmol 9:2772–2780
Kantarci O, Siva A (2006) Behçet’s disease: diagnosis and management (Chapter 96). In: Noseworthy J (ed) Neurological Therapeutics: Principles and Practice. Second edition. Informa Healthcare, pp 1196–1206
Karandreas N, Tsivgoulis G, Zambelis T, Kokotis P, Rapidi A, Petropoulou K, Spengos K (2007) Urinary frequency in a case of Neuro-Behçet disease involving the brainstem — clinical, electrophysiological and urodynamic features. Clin Neurol Neurosurg 109:806–810
Karatas GK, Onder M, Meray J (2002) Autonomic nervous system involvement in Behçet’s disease. Rheumatol Int 22:155–159
Kececi H, Akyol M (2001) P300 in Behçet’s patients without neurological manifestations. Can J Neurol Sci 28:66–69
Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behçet’s syndrome. Brain 122:2171–2181
Kidd D (2006) The prevalence of headache in Behçet’s syndrome. Rheumatology 45:621–623
Kikuchi S, Niino M, Shinpo K, et al. (2002) Intracranial hemorrhage in neuro-Behçet’s syndrome. Intern Med 41:692–695
Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive Neuro-Behçet’s syndrome. J Neurol Sci 272:99–105
Kizilkilic O, Albayram S, Adaletli I, et al. (2003) Endovascular treatment of Behçet’s disease-associated intracranial aneurysms: report of two cases and review of the literature. Neuroradiology 45:328–334
Koç Y, Güllü I, Akpek G, et al. (1992) Vascular involvement in Behçet’s disease. J Rheumatology 19:402–410
Koçer N, Islak C, Siva A, Saip S, Akman C, Kantarci O, Hamuryudan V (1999) CNS involvement in Neuro-Behçet’s syndrome: an MR study. AJNR 20:1015–1024
Kotake S, Higashi K, Yoshikawa K, Sasamato Y, Okamoto T, Matsuda H (1999) Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology 106:586–589
Kotter I, Gunaydin I, Batra M, Vonthein R, Stubiger N, Fierlbeck G, Melms A (2006) CNS involvement occurs more frequently in patients with Behçet’s disease under cyclosporin A than under other medications results of a retrospective analysis of 117 cases. Clin Rheumatol 25:482–486
Krausea I, Weinberger A (2008) Behçet’s disease. Curr Opin Rheumatol 20:82–87
Krespi Y, Akman-Demir G, Poyraz M, Tugcu B, Coban O, Tuncay R, Serdaroğlu P, Bahar S (2001) Cerebral vasculitis and ischaemic stroke in Behçet’s disease: report of one case and review of the literature. Eur J Neurol 8:719–722
Kural-Seyahi E, Fresko I, Seyahi N, et al. (2003) The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60
Kurtzke JF (1983) Rating neurological impairment in MS: An expended disability status scale (EDSS). Neurology 33:1444–1452
Lakhanpal S, O’Duffy JD, Lie JT (1998) Pathology. In: Plotkin GR, Calabro JJ, O’Duffy JD (eds) Behçet’s disease. A contemporary synopsis. Futura, New York, pp 101–142
Licata G, Pinto A, Tuttolomondo A, Banco A, Ciccia F, Ferrante A, Triolo G (2003) Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet’s syndrome. Ann Rheum Dis 62:280–281
Lannuzel A, Lamaury I, Charpentier D, Caparros-Lefebvre D (2002) Neurological manifestations of Behçet’s disease in a Caribbean population: clinical and imaging findings. J Neurol 249:410–418
Matsuo K, Yamada K, Nakajima K, Masanori Nakagawa (2005) Neuro-Behçet disease mimicking brain tumor. AJNR Am J Neuroradiol 26:650–653
Miller DH, Ormerod IEC, Gibson A, DuBoulay EPGH, Rudge P, McDonald WI (1987) MRI brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 29:226–23l
Mitsui Y, Mitsui M, Urakami R, Kihara M, Takasahi M, Kusunoki S (2005) Behçet disease presenting with neurological complications immediately after conversion from conventional cyclosporin A to icroemulsion formulation. Int Med 44:149–152
Monastero R, Mannino M, Lopez G, et al. (2003) Prevalence of headache in patients with Behçet’s disease without overt neurological involvement. Cephalalgia 23:105–108
Morrissey SP, Miller DH, Harmszewski R, et al. (1993) Magnetic resonance imaging of the central nervous system in Behçet’s disease. Eur Neurol 33:287–293
Namer IJ, Karabudak R, Zileli T, et al. (1987) Peripheral nervous system involvement in Behçet’s Disease. Eur Neurol 26:235–240
Nobili F, Cutolo M, Sulli A, et al. (2002) Brain functional involvement by perfusion SPECT in systemic sclerosis and Behçet’s disease. Ann N Y Acad Sci 966:409–414
O’Duffy JD, Robertson DM, Goldstein NP (1984) Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet’s disease. Am J Med 76:75–84
O’Duffy JD (1990) Vasculitis in Behçet’s disease. Rheum Dis Clin North Am 16:423–431
Oktem-Tanor O, Baykan-Kurt B, Gurvit IH, Akman-Demir G, Serdaroğlu P (1999) Neuropsychological follow-up of 12 patients with neuro-Behçet disease. J Neurol 246:113–119
Özdoğan H (1994) Behçet’s syndrome in children. Rheumatology in Europe 23(Suppl 12):34
Patel AV, Stickler DE, Tyor WR (2007) Neurosarcoidosis. Curr Treat Options Neurol 9:161–168
Pellechia MT, Cuomo T, Striano S, et al. (1999) Paroxysmal dystonia in Behçet’s disease. Mov Disord 14:177–179
Perniciaro C, Molina J (1991) Cerebrovascular aneurysms in patients with Behçet’s disease. In: O’Duffy JD, Kökmen E (eds) Behçet’s disease: Basic and clinical aspects. New York: Marcel Dekker, pp 119–123
Park JH, Jung MK, Bang CO, Park MK, et al. (2002) Neuro-Behçet’s disease mimicking a cerebral tumor: a case report. J Korean Med Sci 17:718–722
Park DM (2008) Neurosarcoidosis. In: Gilman S (ed) MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com, accessed August 1, 2008
Ramachandran TR (2008) Cogan’s syndrome. In: Gilman S (ed) MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com, accessed August 1, 2008
Ribi C, Sztajzel R, Delavelle J, Chizzolini C J (2005) Efficacy of TNF a blockade in cyclophosphamide resistant neuro-Behçet disease. Neurol Neurosurg Psychiatry 76:1733–1735
Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44:1977–1983
Sağduyu A, Sirin H, Oksel F, et al. (2002) An unusual case of Behçet’s disease presenting with bilateral internal carotid artery occlusion. J Neurol Neurosurg Psychiatry 73(3):343
Said G (2000) Sarcoidosis of the nervous system. Neurological manifestations in systemic diseases. ENS Teaching Course 12, Syllabus, pp 74–85
Saip S, Siva A, Altıntas A, et al. (2005) Headache in Behçet’s syndrome. Headache 45:911–919
Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 341:1284–1291
Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62:442–451
Sarui H, Maruyama T, Ito I, et al. (2002) Necrotising myositis in Behçet’s disease: characteristic features on magnetic resonance imaging and a review of the literature. Ann Rheum Dis 61:751–752
Sarwar H, McGrath H Jr, Espinoza LR (2005) Successful treatment of longstanding neuro-Behçet’s disease with infliximab in patients with refractory disease. J Rheumatol 32:181–118
Schmolck H (2005) Large thalamic mass due to neuro-Behçet disease. Neurology 65:436
Serdaroğlu P, Yazici H, Özdemir C, et al. (1989) Neurological involvement in Behçet’s syndrome: a prospective study. Arch Neurol 46:265–269
Serdaroğlu P (1998) Behçet’s disease and the nervous system. J Neurol 245:197–205
Serdaroğlu P (1989) Neuromuscular manifestations in the course of Behçet’s Disease. Acta Myologica 2:41–45
Siva A, Özdogan H, Yazici H, et al. (1986) Headache, neuro-psychiatric and computerized tomography findings in Behçet’s syndrome. In: Lehner T, Barnes CG (eds) Recent advances in Behçet’s disease. Royal Society of Medicine Service, London, pp 247–254
Siva A, Necdet V, Yurdakul S, et al. (1991) Neuroradiological findings in Neuro-Behçet Syndrome. In: O’Duffy JD, Kökmen E (eds) Behçet’s disease: Basic and clinical aspects. Marcel Dekker, New York, pp 323–329
Siva A, Altıntas¸ A (2000) Neuro-Behçet Syndrome. In Said G (ed) Intravenous Immunoglobulins in the Treatment of Neurological Disorders. Martin Dunitz Publishers, London, pp 115–126
Siva A, Fresko I (2000) Behçet’s Disease. Current Treatment Options in Neurology 2:435–447
Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazici H (2001) Behçet’s disease: diagnostic & prognostic aspects of neurological involvement. J Neurol 248:95–103
Siva A (2001) Vasculitis of the nervous system. J Neurol 248:451–468
Siva A, Altıntas¸ A, Saip S (2004) Behçet’s syndrome and the nervous system. Curr Opin Neurol 17:347–357
Sener RN (2003) Neuro-Behçet’s disease: diffusion MR imaging and proton MR spectroscopy. Am J Neuroradiol 24:1612–1614
Sfikakis PP, Markomichelakis N, Alpsoy E, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H (2007) Anti-TNF therapy in the management of Behçet’s disease: review and basis for recommendations. Rheumatology 46:736–741
St. Clair EW, McCallum RM (1999) Cogan’s syndrome. Curr Opin Rheumatol 11:47–52
Stigsby B, Bohlega S, McLean DR, Al-Kawi MZ (2000) Transcranial magnetic stimulation in Behçet’s disease: a cross-sectional and longitudinal study with 44 patients comparing clinical, neuroradiological, somatosensory and brain-stem auditory evoked potential findings. Clin Neurophysiol 111:1320–1329
Susac JO, Egan RA, Rennebohm RM, Lubow M (2007) Susac’s syndrome: 1975–2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci 257:270–272
Takeuchi A, Kodama M, Takatsu M, et al. (1989) Mononeruritis multiplex in incomplete Behçet’s Disease: A case report and the review of the literature. Clin Rheumatol 8:375–380
Tunc T, Ortapamuk H, Naldoken S, Ergun U, Ciliz D, Atasoy HT, Okuyucu E, Inan LE, Eksioglu M (2006) Subclinical neurological involvement in Behçet’s disease. Neurol India 54:408–411
Tunc R, Saib S, Siva A, Yazici H (2004) Cerebral venous thrombosis is associated with major vessel disease in Behçet’s syndrome. Ann Rheum Dis 63:1693–1694
Wechsler B, Vidailhet M, Bousser MG, et al. (1992) Cerebral venous sinus thrombosis in Behçet’s disease: Long term follow-up of 25 cases. Neurology 42:614–618
Yazıcı H, Yurdakul S, Hamuryudan V (2001) Behçet disease [Vasculitis syndromes]. Curr Opin Rheumatol 13:18–22
Yazıcı H (2003) Behçet syndrome: an update. Curr Rheumatol Rep 5:195–219
Yazıcı H, Fresko I, Yurdakul S (2007) Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nature Clinical Practice Rheumatology 3:151–155
Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroğlu P, Akman-Demir G (2007) Clinical characteristics and course of spinal cord involvement in Behçet’s disease. Eur J Neurol 14:729–737
Yesilot N, Shehu M, Oktem-Tanor O, et al. (2006) Silent neurological involvement in Behçet’s disease. Clin Exp Rheumatol 24:S65–S70
Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. (1997) Epidemiological features of Adamantiades-Behçet’s disease in Germany and in Europe. Yonsei Med J 38:411–422
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Siva, A., Saip, S. The spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis. J Neurol 256, 513–529 (2009). https://doi.org/10.1007/s00415-009-0145-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-0145-6